Microbial dysbiosis |
P. gingivalis
|
|
Fusobacterium
|
|
Helicobacter pylori
|
The Helicobacter pylori IgG level was higher in PDAC
Helicobacter pylori may promote the development of PDAC by causing chronic mucosal inflammation as well as changes in cell proliferation and differentiation.
|
Hepatotropic viruses HBV and HCV
|
HBsAg and HBcAg were found in the cytoplasm of pancreatic acinar cells
Inflammation and modifying tissue viscoelasticity, DNA integration in infected cells that delay host immune system clearance of HBV/ HCV-containing cells
Modulating the PI3K/AKT signaling pathway via the HBV/HCV protein
|
Gammaproteobacteria
Bifidobacterium pseudolongum
|
|
Other: Fungi and viruses |
Oncogenic Kras-induced inflammation leads to fungal dysbiosis, which in turn promotes tumor progression via activation of the MBL-C3 cascade.
The fungal microbiome drives a KrasG12D-MEK signaling pathway in PDAC cells that promotes the secretion of a pro-inflammatory cytokine, IL-33, which can subsequently hasten the spread of PDAC by secreting pro-tumorigenic cytokines such as IL-4, IL-5, and IL-13.
|
Microbial metabolites |
lipopolysaccharide (LPS) |
A Gram-negative bacterial cell wall component
LPS can interact with several TLRs signaling pathways leading to T-cell anergy.
LPS-TLR signaling can activate NF-κB, MAPK, the signal transducers and activators of STAT3 signaling pathway and trigger mutation of KRAS
|
deoxycholic acid (DCA) and short-chain fatty acids (SCFAs) |
They both promote intestinal tumorigenesis in conjunction with adenomatous polyposis coli (Apc) gene mutation
Causing DNA damage, modulating the inflammatory cytokines and chemokines expressing in the PDAC TME via activation of Wnt signaling which is important for cell proliferation during tumorigenesis.
DCA can activate the epidermal growth factor receptor (EGFR)
|